Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Nevro Corp (NVRO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,884,955
  • Shares Outstanding, K 30,378
  • Annual Sales, $ 387,290 K
  • Annual Income, $ -49,210 K
  • 60-Month Beta 0.14
  • Price/Sales 4.84
  • Price/Cash Flow N/A
  • Price/Book 7.59

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate -0.66
  • Number of Estimates 7
  • High Estimate -0.59
  • Low Estimate -0.80
  • Prior Year -0.59
  • Growth Rate Est. (year over year) -11.86%

Price Performance

See More
Period Period Low Period High Performance
1-Month
42.82 +46.19%
on 03/15/19
63.84 -1.94%
on 03/25/19
+18.47 (+41.85%)
since 02/25/19
3-Month
35.15 +78.09%
on 01/03/19
63.84 -1.94%
on 03/25/19
+27.17 (+76.69%)
since 12/24/18
52-Week
34.75 +80.14%
on 12/20/18
94.34 -33.64%
on 05/07/18
-23.40 (-27.21%)
since 03/23/18

Most Recent Stories

More News
Shares of Nevro Corp Rank the Highest in Terms of Relative Performance in the Health Care Equipment Industry (NVRO , VAR , GKOS , RMD , NUVA )

We looked at the Health Care Equipment industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We...

NVRO : 62.60 (+0.89%)
VAR : 138.71 (+0.09%)
GKOS : 80.07 (-0.04%)
Why 2019 U.S. Medical Device Market Is Expected to Exceed Last Year Revenues

A recent article in a medical device industry periodical, INN, said that: "2018 has been an important year for the medical device industry as M&A, technology and regulatory catalysts have impacted the...

NVRO : 62.60 (+0.89%)
MTFB : 1.90 (-15.56%)
CPRX : 5.24 (+30.35%)
PAVM : 1.04 (+0.97%)
SOLY : 7.21 (-7.80%)
Nevro Corp Rises 33.82% on Heavy Volume: Watch For Potential Pullback

Nevro Corp (NYSE:NVRO) traded in a range yesterday that spanned from a low of $55.99 to a high of $60.70. Yesterday, the shares gained 33.8%, which took the trading range above the 3-day high of $45.12...

NVRO : 62.60 (+0.89%)
Thinking about buying stock in Aurora Cannabis Inc., China Bat Group Inc., Nevro Corp., Shineco Inc., or Vaxart Inc.?

InvestorsObserver issues critical PriceWatch Alerts for ACB, GLG, NVRO, TYHT, and VXRT.

NVRO : 62.60 (+0.89%)
ACBFF : 8.6900 (-12.80%)
TYHT : 1.01 (-8.18%)
Nevro Announces New CEO, Board Appointments and Agreement with Broadfin Capital

Nevro Corp. (NYSE: NVRO) ("Nevro"), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain, today announced that D. Keith Grossman has been...

NVRO : 62.60 (+0.89%)
Nevro (NVRO) Q4 Loss Wider Than Expected, Revenues Beat

Nevro's (NVRO) solid domestic and international performance aids Q4 results.

NVRO : 62.60 (+0.89%)
SYK : 195.17 (+0.38%)
VAR : 138.71 (+0.09%)
CNMD : 80.75 (+1.17%)
Nevro Corp Set to Possibly Rebound After Yesterday's Selloff of 11.92%

Nevro Corp (NYSE:NVRO) traded in a range yesterday that spanned from a low of $41.73 to a high of $44.03. Yesterday, the shares fell 11.9%, which took the trading range below the 3-day low of $46.20...

NVRO : 62.60 (+0.89%)
Nevro: 4Q Earnings Snapshot

REDWOOD CITY, Calif. (AP) _ Nevro Corp. (NVRO) on Thursday reported a loss of $9.6 million in its fourth quarter.

NVRO : 62.60 (+0.89%)
Nevro (NVRO) Reports Q4 Loss, Tops Revenue Estimates

Nevro (NVRO) delivered earnings and revenue surprises of -88.24% and 0.53%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?

NVRO : 62.60 (+0.89%)
Nevro Files Lawsuit for Patent Infringement Against Stimwave in the U.S.

Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain, today announced that it has filed a lawsuit for patent...

NVRO : 62.60 (+0.89%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Trade NVRO with:

Business Summary

Nevro Corp. is a medical device company. It engages in developing and commercializing a neuromodulation platform for the treatment of chronic pain. The Company provides pain relief to the customers suffering from low back pain and types of chronic pains. Nevro has developed and commercialized the Senza...

See More

Key Turning Points

2nd Resistance Point 65.05
1st Resistance Point 63.83
Last Price 62.60
1st Support Level 61.39
2nd Support Level 60.17

See More

52-Week High 94.34
Fibonacci 61.8% 71.58
Fibonacci 50% 64.54
Last Price 62.60
Fibonacci 38.2% 57.51
52-Week Low 34.75

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar